ARTICLE | Company News
BioVeris, Baxter deal
February 5, 2007 8:00 AM UTC
BIOV received exclusive worldwide rights to develop BAX’s Neisseria meningitidis group Y and Haemophilus influenza type b (Hib) vaccines as components in new combination vaccines to prevent meningitis...